Other substances

Natamycin

A polyene antifungal.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

Natamycin on PubChem

Marketed as

DELVOCID; FUKRICIN; INFECTOMYK; N-MYCIN; NATACYN; NATADROPS; NATAMET; NATAMYCYNA; NATEZHEN; NATOPH; NATOPTIC; OPTINAT; PIMAFUCIN; PIMAFUSIN; PIMARICIN

 

Structure image - Natamycin

C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)O)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)N)O


 

Supporting references

Link Tested on Impact factor Notes Publication date
Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs
3CLpro PapainLpro RdRpol Small molecule In silico 		in silico

Predicted to inhibit SARS-CoV-2 RNA-dependent RNA polymerase.

 Jan/18/2021
Export (.csv)